FACDX
Price
$54.20
Change
-$1.91 (-3.40%)
Updated
Mar 10 closing price
Net Assets
3.96B
FSPHX
Price
$26.54
Change
-$0.94 (-3.42%)
Updated
Mar 10 closing price
Net Assets
6.74B
Ad is loading...

FACDX vs FSPHX

Header iconFACDX vs FSPHX Comparison
Open Charts FACDX vs FSPHXBanner chart's image
Fidelity Advisor Health Care A
Price$54.20
Change-$1.91 (-3.40%)
VolumeN/A
Net Assets3.96B
Fidelity Select Health Care
Price$26.54
Change-$0.94 (-3.42%)
VolumeN/A
Net Assets6.74B
FACDX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FACDX vs. FSPHX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACDX is a Buy and FSPHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.74B vs. FACDX (3.96B). FSPHX pays higher dividends than FACDX: FSPHX (0.02) vs FACDX (0.00). FACDX was incepted earlier than FSPHX: FACDX (29 years) vs FSPHX (44 years). FACDX (0.93) is less costly to investors than FSPHX (0.65). FSPHX is a more actively managed with annual turnover of: 46.00 vs. FACDX (37.00). FACDX (0) and FSPHX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : -9.89 vs. FACDX (-11.64). FACDX return over 5 years is better than : 12.15 vs. FSPHX (7.38).
FACDXFSPHXFACDX / FSPHX
Total Expense Ratio0.930.65143%
Annual Report Gross Expense Ratio0.930.65143%
Fund Existence29 years44 years-
Gain YTD0.8990.844107%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets3.96B6.74B59%
Annual Yield % from dividends0.000.02-
Returns for 1 year-11.64-9.89118%
Returns for 3 years0.140.8617%
Returns for 5 years12.157.38165%
Returns for 10 years31.9314.97213%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVAIX38.14N/A
N/A
JPMorgan Value Advantage L
LADQX16.61N/A
N/A
Lord Abbett Developing Growth R2
SILVX17.80N/A
N/A
SGI US Large Cap Equity I
DCUAX14.06N/A
N/A
DWS CROCI US A
IPFCX29.07N/A
N/A
Poplar Forest Cornerstone Investor